Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBLB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphomaActive, not recruitingPhase 22024-02-14NCT03620578

1 results · Page 1 of 1

Swipe the table sideways for more columns.

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BE-Antwerpen-ZNASTUIVENBERGAntwerpBelgium8
BE-Leuven-UZLEUVENLeuvenBelgium10
NL-Almere-FlevoziekenhuisAlmere StadNetherlands4
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam-AMCAmsterdamNetherlands10
NL-Amsterdam-VUMCAmsterdamNetherlands10
NL-Den Bosch-JBZ's-HertogenboschNetherlands14
NL-Den Haag-HAGAThe HagueNetherlands13
NL-Eindhoven-MAXIMAMCEindhovenNetherlands11
NL-Enschede-MSTEnschedeNetherlands11
NL-Goes-ADRZGoesNetherlands5
NL-Groningen-UMCGGroningenNetherlands17
NL-Hoofddorp-SPAARNEGASTHUISHoofddorpNetherlands7
NL-Hoorn-DIJKLANDERHOORNHoornNetherlands2
NL-Leeuwarden-MCLLeeuwardenNetherlands10
NL-Leiden-LUMCLeidenNetherlands9
NL-Maastricht-MUMCMaastrichtNetherlands13
NL-Nijmegen-RADBOUDUMCNijmegenNetherlands11
NL-Rotterdam-ERASMUSMCRotterdamNetherlands14
NL-Rotterdam-MAASSTADZIEKENHUISRotterdamNetherlands3
NL-Sittard-Geleen-ZUYDERLANDSittardNetherlands5
NL-Tilburg-ETZTilburgNetherlands5
NL-Utrecht-UMCUTRECHTUtrechtNetherlands16
NL-Zwolle-ISALAZwolleNetherlands13